Tag - DCPH

Markets

Stifel cuts Deciphera Pharma to hold; PT to $10 from $60

Stifel downgraded Deciphera Pharmaceuticals (NASDAQ:DCPH) to “hold” from “buy” and slashed its price target to $10 from $60 after the failure of the company’s Qinlock in 2L gastrointestinal stromal tumor (GIST). Shares...

November 8, 2021

Markets

SVB Leerink ups Deciphera Pharma to MP; PT to $34 from $29

SVB Leerink upgraded Deciphera Pharmaceuticals (NASDAQ:DCPH) to “market perform” from “underperform” and raised its price target to $34 from $29 after the FDA decided to split competitor Blueprint Medicines’ NDA...

October 29, 2019

Tag - DCPH

Stifel cuts Deciphera Pharma to hold; PT to $10 from $60

SVB Leerink ups Deciphera Pharma to MP; PT to $34 from $29

General

More